Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04700072 |
|---|---|
| Brief Title: | Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02) |
| First Submitted : | January 5, 2021 |
| First Submitted that Met QC Criteria : | January 5, 2021 |
| First Posted : | January 7, 2021 |
| Last Update Submitted that Met QC Criteria : | January 25, 2023 |
| Last Update Posted : | January 26, 2023 |